2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1093211922 MD
Verify on CMS →

ANNE DE ROSAIRO, MD

Endocrinology, Diabetes & Metabolism Physician in JERSEY CITY, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
646
Medicare Part D claims · 174 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$79.51
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ANNE DE ROSAIRO, MD is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in JERSEY CITY, New Jersey with a Medicare Part D prescribing footprint of 646 claims across 174 beneficiaries — 17% brand-name prescribing . Industry payments of $79.51 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ANNE DE ROSAIRO, MD filed 646 Medicare Part D claims in 2023 across JERSEY CITY, New Jersey. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

ANNE DE ROSAIRO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ANNE DE ROSAIRO, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/31/2018

NPI 1093211922

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

646 76% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in New Jersey

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers

New Jersey providers

Endocrinology, Diabetes & Metabolism Physician share within New Jersey

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANNE DE ROSAIRO, MD is a Endocrinology, Diabetes & Metabolism Physician provider practicing in JERSEY CITY, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1093211922. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ANNE DE ROSAIRO, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 377 JERSEY AVE STE 220, JERSEY CITY, NJ, 07302, with a listed phone of (201) 915-2380. NPI 1093211922 was issued on 03/31/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DE ROSAIRO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 646 prescription claims written by this provider, covering 174 Medicare beneficiaries and totaling roughly $100K in drug spend, split 17% brand-name and 83% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

377 JERSEY AVE STE 220
JERSEY CITY, NJ 07302

Provider Details

NPI 1093211922
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 03/31/2018

Hospital and facility affiliations

Facilities where ANNE DE ROSAIRO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BARNABAS HEALTH MEDICAL GROUP PC
BAYONNE, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ANNE DE ROSAIRO, MD. Source: openpaymentsdata.cms.gov.

Total received

$80

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

ANNE DE ROSAIRO, MD — brand share 17.0%
Specialty average (est.)

17% brand-name claims vs 83% generic, on 646 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

646
Total Claims
$100K
Total Drug Cost
174
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,158
Total Day Supply
32,271
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$83K
Generic Drug Cost
$16K
Antibiotic Claims
46

Patient Demographics

Average Patient Age
70.6 years
Avg HCC Risk Score
1.62
Gender Split
72% female / 28% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Losartan Potassium
35
Atorvastatin Calcium
29
Levothyroxine Sodium
29
Azithromycin
25
Metformin Hcl
19
Metoprolol Succinate
19
Albuterol Sulfate Hfa
Albuterol Sulfate
17
Gabapentin
15
Sertraline Hcl
14
Simvastatin
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ANNE DE ROSAIRO, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ANNE DE ROSAIRO, MD's 646 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as DE ROSAIRO.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANNE DE ROSAIRO, MD's specialty?
ANNE DE ROSAIRO, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in JERSEY CITY, New Jersey. Credentials: MD.
How much does ANNE DE ROSAIRO, MD prescribe under Medicare Part D?
In 2023, ANNE DE ROSAIRO, MD wrote 646 Medicare Part D claims totaling $100K in drug costs for 174 beneficiaries.
Where is ANNE DE ROSAIRO, MD located?
ANNE DE ROSAIRO, MD is located at 377 JERSEY AVE STE 220, JERSEY CITY, NJ, 07302. Phone: (201) 915-2380.
What is ANNE DE ROSAIRO, MD's NPI number?
ANNE DE ROSAIRO, MD's National Provider Identifier (NPI) is 1093211922, issued on 03/31/2018.
Does ANNE DE ROSAIRO, MD prescribe more brand-name or generic drugs?
ANNE DE ROSAIRO, MD's prescribing is 17% brand-name and 83% generic drugs by claim count, with $83K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ANNE DE ROSAIRO, MD prescribe most often?
Based on 2023 Medicare Part D data, ANNE DE ROSAIRO, MD's most frequently prescribed drugs include Losartan Potassium, Atorvastatin Calcium, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANNE DE ROSAIRO, MD accept Medicare?
ANNE DE ROSAIRO, MD appears in CMS Medicare data with 646 Part D claims and 174 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANNE DE ROSAIRO, MD's credentials?
ANNE DE ROSAIRO, MD's NPI is 1093211922 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology